VCM
NVO

Versant Capital Management’s Novo Nordisk NVO Stock Holding History

Versant Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Buy
9,969
+1,589
+19% +$68.3K 0.04% 308
2026
Q1 		$308K Sell
8,380
-1,504
-15% -$71.3K 0.03% 424
2025
Q4 		$503K Buy
9,884
+2,845
+40% +$145K 0.06% 222
2025
Q3 		$391K Sell
7,039
-1,135
-14% -$66.4K 0.05% 266
2025
Q2 		$564K Sell
8,174
-1,214
-13% -$82.6K 0.09% 146
2025
Q1 		$652K Buy
9,388
+8,392
+843% +$693K 0.11% 114
2024
Q4 		$85.7K Buy
+996
New +$108K 0.02% 358
2023
Q4 		– Sell
-116
Closed -$10.5K – 1982
2023
Q3 		$10.5K Hold
116
– – ﹤0.01% 711
2023
Q2 		$9.39K Hold
116
– – ﹤0.01% 799
2023
Q1 		$9.23K Buy
+116
New +$8.23K ﹤0.01% 736
2018
Q1 		– Sell
-400
Closed -$10K – 1603
2017
Q4 		$10K Buy
+400
New +$10.2K ﹤0.01% 917

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
ERP
Eldred Rock Partners San Antonio, Texas $465M AUM 48.86% 1-Year Est. Return

Versant Capital Management's NVO Position: Q2 2026 in Review

Versant Capital Management increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $68.3K and bringing the position to 9,969 shares worth $478K. The position accounts for 0.04% of the portfolio, ranked #308.

Versant Capital Management first reported a position in NVO in Q4 2017 and has held it in 11 quarters since. The position peaked at $652K in Q1 2025. 214 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Versant Capital Management held 9,969 shares of Novo Nordisk worth $478K as of Q2 2026.
  • Versant Capital Management bought 1,589 Novo Nordisk shares in Q2 2026, an estimated $68.3K.
  • Novo Nordisk made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #308 holding.
  • Versant Capital Management first reported a position in Novo Nordisk in Q4 2017 and has held it in 11 quarters since.
  • Versant Capital Management's Novo Nordisk position peaked at $652K in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.